Preformulation and Vaginal Film Formulation Development of Microbicide Drug Candidate CSIC for HIV prevention.

about

Preformulation and Vaginal Film Formulation Development of Microbicide Drug Candidate CSIC for HIV prevention.

Item

http://www.wikidata.org/entity/Q41990616

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Preformulation and Vaginal Fil ...... idate CSIC for HIV prevention.

@en

type

Item

label

Preformulation and Vaginal Fil ...... idate CSIC for HIV prevention.

@en

prefLabel

Preformulation and Vaginal Fil ...... idate CSIC for HIV prevention.

@en

P1476

Preformulation and Vaginal Fil ...... idate CSIC for HIV prevention.

@en

P2093

Bernard Moncla

http://www.w3.org/2001/XMLSchema#string

Kerry M Empey

http://www.w3.org/2001/XMLSchema#string

Lisa C Rohan

http://www.w3.org/2001/XMLSchema#string

Michael A Parniak

http://www.w3.org/2001/XMLSchema#string

Phalguni Gupta

http://www.w3.org/2001/XMLSchema#string

Phillip W Graebing

http://www.w3.org/2001/XMLSchema#string

Tiantian Gong

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Water dispersible microbicidal cellulose acetate phthalate film

Patterns of resistance and cross-resistance to human immunodeficiency virus type 1 reverse transcriptase inhibitors in patients treated with the nonnucleoside reverse transcriptase inhibitor loviride

The search for potent, small molecule NNRTIs: A review.

A novel itraconazole bioadhesive film for vaginal delivery: design, optimization, and physicodynamic characterization.

Increased Dapivirine tissue accumulation through vaginal film codelivery of dapivirine and Tenofovir.

A vaginal fluid simulant.

Virion instability of human immunodeficiency virus type 1 reverse transcriptase (RT) mutated in the protease cleavage site between RT p51 and the RT RNase H domain.

A tight-binding mode of inhibition is essential for anti-human immunodeficiency virus type 1 virucidal activity of nonnucleoside reverse transcriptase inhibitors.

Acceptability research on female-controlled barrier methods to prevent heterosexual transmission of HIV: Where have we been? Where are we going?

Targeted delivery of PSC-RANTES for HIV-1 prevention using biodegradable nanoparticles.

P2888

s12247-017-9274-0

P304

142-154

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12247-017-9274-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28983328

http://www.w3.org/2001/XMLSchema#string

P921

prevention of HIV/AIDS

P932

5624728

http://www.w3.org/2001/XMLSchema#string